Mechanism and Research Interest

Primary Biological Pathway: G-Protein Coupled Receptor Activation

The research utility of VIP stems from its high-affinity binding to the VPAC1 and VPAC2 receptors. Upon binding, these receptors trigger the adenylate cyclase-cAMP-PKA signalling cascade.

In the context of the 5mg presentation, researchers often focus on the acute effects of this pathway, such as rapid bronchodilation or immediate hypotension (vasodilation) in isolated tissue preparations. The 5mg dose allows for precise bolus administration to observe the kinetics of receptor desensitisation without the waste associated with larger volume pens.

Secondary Research Finding: The Gut-Brain Axis

VIP is densely concentrated in the enteric nervous system (ENS). It is a key inhibitor of smooth muscle tone in the gastrointestinal tract. Research utilising the 5mg format often explores the “VIPergic” innervation of the gut, specifically looking at how the peptide modulates peristalsis and sphincter relaxation. This is highly relevant for models of motility disorders, where VIP acts as a “brake” on excessive smooth muscle contraction.

Tertiary Research Finding: Neuroprotection and Microglial Regulation

Beyond the periphery, VIP exhibits potent neuroprotective properties. It is observed to inhibit the activation of microglia (the brain’s immune cells) in response to trauma or toxins. Researchers use the 5mg pen to investigate the “therapeutic window” of VIP in preventing neuronal apoptosis following excitotoxic injury. The peptide’s ability to release neurotrophic factors (like BDNF) is a key secondary endpoint in these neurological studies.

Long-term Genomic and Safety Observations

While VIP is endogenous, exogenous administration provides insight into feedback loops. Studies are currently analysing the transcriptional impact of VIP on the Per1 and Per2 clock genes within the suprachiasmatic nucleus. The 5mg format is particularly useful for these circadian studies, where dosing must be timed precisely to the organism’s Zeitgeber time (ZT), and the stability of the peptide is paramount for consistent results across different time points.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). We prioritise the elimination of truncated sequences which can act as competitive antagonists.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen ratchet mechanism allows for the administration of micro-litre volumes, essential for intracerebroventricular (ICV) or local tissue perfusion studies.

• Storage: Requires strict temperature control at $2^{\circ}C$ to $8^{\circ}C$.

Storage and Shipping Guidelines

Refrigeration and Shelf Life

The VIP 5mg Pen is highly sensitive to enzymatic degradation and thermal fluctuation. It must be stored at $2^{\circ}C$ to $8^{\circ}C$. The shelf life is 12 months in the sealed state. However, VIP is known for its rapid oxidation rates once in solution. The 5mg format is specifically designed to be consumed rapidly (within 14-21 days of opening) to ensure that the researcher is always using a peptide with maximum structural integrity.

Shipping Stability

We utilise medical-grade cold-chain packaging. The formulation is buffered to remain stable for up to 48 hours in transit. Given the fragile nature of the VIP amino acid chain, we recommend “Next Day” delivery to minimise environmental exposure.

Freezing Warning

Do not freeze. Freezing leads to ice crystal formation that can fracture the peptide backbone ($hydrolysis$) and damage the pen cartridge. A freeze-thaw cycle will result in a significant loss of potency and likely precipitation.

Why Choose the Peptide Pro 3ml Pen Format?

The VIP 5mg Pen is the ideal solution for Pilot Studies and Short-Duration Protocols.

VIP is a notoriously unstable peptide once reconstituted. Researchers purchasing larger quantities (e.g., 10mg or 20mg) often find that the peptide degrades before they can utilise the full volume, leading to data inconsistency in the final weeks of a study.

The 5mg pen eliminates this variable. It provides a “fresh” quantity suitable for smaller cohorts or acute experiments, ensuring that every dose administered is bioactive. It prevents the financial and scientific waste of discarding degraded reagents.

For researchers requiring larger quantities for chronic studies, we recommend:

• VIP 10mg: (For larger cohorts or higher-dose systemic reviews).

• BPC-157 10mg: (For comparative studies on gut motility and repair).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection, therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.